BarnettH. L.: Renal Clearances of Sodium Penicillin G, Procaine Penicillin G and Inulin in Infants and Children, Pediatrics3: 418–422, 1949.
2.
LevinB., and NeillC. A.: Oral Penicillin in Newborn, Arch. Diseases Children24: 171–179, 1949.
3.
HuntA. D.Jr., and FellM. B.: Streptomycin Intramuscular Dosage per Unit Body Weight Correlated with Serum Levels in Infants and Children, Pediatrics4: 163–169, 1949.
4.
BrownA. K., and ZuelerW. W.: Studies on Neonatal Development of Glucuronide Conjugating System, J. Clin. Invest.37: 332–340, 1958.
5.
DriscollS. G., and HsiaD. Y. Y.: Development of Enzyme Systems During Early Infancy, Pediatrics22: 785–845, 1958.
6.
KretchmerH.: Enzymatic Patterns During Development: Approach to Biochemical Definition of Immaturity, Pediatrics23: 606–617, 1959.
7.
FoutsJ. R., and AdamsonR. H.: Drug Metabolism in Newborn Rabbit, Science129: 897–898, 1959.
8.
WeissC. F., GlazkoA. J., and WestonJ. K.: Chloramphenicol in the Newborn Infant. A Physiologic Explanation of Its Toxicity When Given in Excessive Doses, New Engl. J. Med.262: 787–794, 1960.
9.
EichenwaldH. F., and ShinefieldH. R.: Antimicrobial Therapy in Neonatal Period, Pediat. Clin. N. Am.8: 509–523, 1961.
10.
NyhanW. L.: Toxicity of Drugs in Neonatal Period, J. Pediat.59: 1–20, 1961.
11.
SutherlandJ. M., and MohlmanY. M.: Antimicrobial Therapy in Newborn Infant, Pediat. Clin. N. Am.8: 1143–1160, 1961.
12.
ZiegraS. R., and StormR. R.: Dosage of Chloramphenicol in Premature Infants, J. Pediat.58: 852–857, 1961.
13.
HodgmanJ. E., and BurnsL. E.: Safe and Effective Chloramphenicol Dosages for Premature Infants, Am. J. Diseases Children101: 140–148, 1961.
14.
BurnsL., and HodgmanJ. E.: Studies in Prematures Given Erythromycin Estolate, Am. J. Diseases Children106: 280–288, 1963.
15.
CohlanS. Q., BevelanderG., and TiamsicT.: Growth Inhibition of Prematures Receiving Tetracycline, Am. J. Diseases Children105: 453–461, 1963.
16.
FujiiR., KonnoM., MatuzakiM., TakeshitaM., and UnoS.: The Absorption and the Excretion of Intramuscularly Administered Chloramphenicol in the Pediatric Age, Especially in the Newborn and Premature Infants, J. Antibiotics (Tokyo) Ser. B.16: 371–377, 1963.
17.
MedovyH.: Therapeutic Hazards for the Nursery Infant, Postgrad. Med.34: 537–545, 1963.
18.
DearbornE. H., and BagdonR. E.: Safety Evaluation of Drugs in the Newborn, presented before the Pharmaceutical Manufacturers Association, Research and Development Section, White Sulphur Springs, W. Va., November 4-6, 1963.
19.
PercyA. K., and YaffeS. J.: Sulfate Metabolism During the Mammalian Development, Pediatrics33: 965–968, 1964.
20.
AarskogD., StoaK. F., and ThorsenT.: Cortisol Metabolism in the Newborn. Urinary Excretion of Free and Conjugated Compounds Following Intravenous Administration of Cortisol-4-14C, Acta Endocrinol.45: 286–296, 1964.
21.
YaffeS. J.: Antibiotic Dosage in Newborn and Premature Infants, J. Am. Med. Assoc.193: 818–820, 1965.
22.
von HarnackG. A., NaumannP., MaiK.: Blood Levels of Oxacillin in the First Three Months of Life, German Med. Monthly10: 499–502, 1965.
23.
SereniF. L., PerlettiL., ManfrediN.: Tissue Distribution and Urinary Excretion of a Tetracycline Derivative in New Born and Older Infants, J. Pediat.67: 299–305, 1965.
24.
NitowskyM. D., MatzL., and BerzofskyJ. A.: Studies on Oxidative1 Drug Metabolism in the Full-Term Newborn Infant, J. Pediat.69: 1139–1149, 1966.
25.
VestM.: Metabolism and Therapeutic Effect of a Long-Acting Sulfonamide, 4-Sulfanilamide-5,6-Dimethoxy-pyrimidine (Fanasil) in Infants and Children, Schweiz. Med. Wochschr.96: 920–928, 1966.
26.
HjelmM., and SjolinS.: Changes in the Elimination Rate from Blood of Intravenously Injected Galactose During the Neonatal Period, Scand. J. Clin. Lab. Invest.18: 126, 1966 (Suppl. 92).
27.
AxlineS. G., YaffeS. J., and SimonH. J.: Clinical Pharmacology of Antimicrobials in Premature Infants: II. Ampicillin, Methicillin, Oxacillin, Neomycin and Colistin, Pediatrics39: 91–107, 1967.
28.
FlynnM. A., HannaF. M., and LutzR. N.: Estimation of Body Water Compartments of Preschool Children, Am. J. Clin. Nutrition20: 1125–1128, 1967.
29.
HarveyC., DohertyJ. E., CharF., and PerkinsW. H.: Studies with Tritiated Digoxin in Infants, Clin. Res.16: 28, 1968.
30.
PearsonK.: Mathematical Contributions to the Theory of Evolution. On A Form of Spurious Correlation Which May Arise When Indices Are Used in the Measurement of Organs, Proc. Roy. Soc. (London)60: 489–498, 1897.
31.
DreyerG., and WalkerE. W. A.: The Dosage of Drugs, Toxins and Antitoxins, Proc. Roy. Soc. (London)87: 51–72, 1914.
32.
Du BoisD., and Du BoisE. F.: A Formula to Estimate the Approximate Surface Area if Height and Weight be Known, Arch. Internal Med.17: 863–871, 1916.
33.
BoydE.: Growth of the Surface Area of the Human Body, Institute of Child Welfare Monograph Series #10, Minneapolis, University of Minnesota Press, 1935.
34.
TannerJ. M.: Fallacy of Per-Weight and Per-Surface Area Standards, and Their Relation to Spurious Correlation, J. Appl. Physiol.2: 1–15, 1949.
35.
CrawfordJ. D., TerryM. E., and RourkeG. M.: Simplification of Drug Dosage Calculation by Application of the Surface Area Principle, Pediatrics5: 783–789, 1950.
36.
OliverW. J., GrahamB. D., and WilsonJ. L.: Lack of Scientific Validity of Body Surface Area as Basis for Parenteral Fluid Dosage, J. Am. Med. Assoc.167: 1211–1218, 1958.
37.
Anon,.: The Surface Area of the Body (editorial), J. Am. Med. Assoc.167: 1248, 1958.
38.
ForbesG. B.: Body Surface Area as Basis for Dosage, Pediatrics23: 3–5, 1959.
39.
PinkelD.: Body Surface and Dosage: Pragmatic View, Quart. Rev. Pediat.14: 187–189, 1959.
40.
TalbotN. B., and RichieR. H.: The Advantages of Surface Area of the Body as a Basis of Calculating Pediatric Dosages, Pediatrics24: 495–495, 1959.
41.
ButlerA. M., and RichieR. H.: Simplification and Improvement in Estimating Drug Dosage and Dietary Allowances for Patients of Varying Sizes, New Engl. J. Med.262: 903–908, 1960.
42.
GlazkoA. J.: Simplified Procedures for Calculating Drug Dosage from Body Weight in Infancy and Childhood, Pediatrics27: 503–506, 1961.
43.
PagetG. E., and BarnesJ. M.: Toxicity Tests, in “Evaluation of Drug Activities: Pharmacometrics,”LaurenceD. R., and BocharachA. L., eds., New York, Academic Press, Vol. 1, 1964, p. 161.
44.
DearbornE. H., and BagdonR. E.: Safety Evaluation of Drugs in the Newborn, presented before the Pharmaceutical Manufacturers Association, Research and Development Section, White Sulphur Springs, W. Va., November 4-6, 1963.
45.
ShirkeyH. C.: Drug Dosage in Infants and Children, J. Am. Med. Assoc.193: 443–446, 1965.
46.
FreireichJ., GehanE. A., RailD. P., SchmidtL. A., and SkipperH. E.: Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey and Man, Cancer Chemotherapy Repts.50: 219–244, 1966.
47.
SnivelyW.D.: Body Surface As a Yardstick for Dosage, Pediatric News April 1967.
48.
ShirkeyH. C.: Body Surface Area Teaching in Pediatrics, J. Am. Med. Assoc.201: 980, 1967.
49.
LeachR. N., and WoodB. S. B.: Drug Dosage for Children, Lancet2: 1350–1351 (Dec. 23) 1967.
50.
RomanoffL. P., MorrisC. W., WelchP.: Metabolism of Progesterone-4-14C in Young and Elderly Men, J. Clin. Endocrinol.23: 286–292, 1963.
51.
ForbesG. B.: Growth of the Lean Body Mass During Childhood and Adolescence, J. Pediat.64: 822–827, 1964.
52.
SappO. L.III, SeasionsJ. T.Jr., and RoseJ. W.Jr.: Effect of Aging on Intestinal Absorption of Sugars, Clin. Res.12: 31, 1964 (#1).
53.
BenderA. D.: Pharmacological Aspects of Aging: A Survey of the Effect of Increasing Age on Drug Activity in Adults, J. Am. Geriat. Soc.12: 114–134, 1964.
54.
ReiterT., HornH., Ben-UzilioR., and FinkelsteinM.: Plasma Levels of Testosterone in Aging Male Patients Following Implantation of Testosterone (Letters), J. Am. Geriat. Soc.12: 515–516, 1964.
55.
AvioliL. V., McDonaldJ. E., and LeeS. W.: The Influence of Age on the Intestinal Absorption of 47Ca in Women and Its Relation to Calcium Absorption in Postmenopausal Osteoporosis, J, Clin. Invest.44: 1960–1967, 1965.
56.
EwyG. A., MarcusF. I., and KapadiaG.: Digoxin Metabolism in the Elderly, Clin. Res.16: 27, 1968.
57.
GuthP. H.: Physiologic Alterations in Small Bowel Function with Age: The Absorption of D-Xylose, Clin. Res.16: 117, 1968.